Core Entrustable Professional Activities in Clinical Pharmacology: Pearls for Clinical Practice Drug-Drug and Food-Drug Interactions

被引:10
|
作者
Hermann, Robert [1 ,5 ]
Derendorf, Hartmut [2 ,5 ]
von Richter, Oliver [3 ,5 ]
Rostami-Hodjegan, Amin [4 ,5 ]
机构
[1] Clin Res Appliance, D-63571 Gelnhausen, Germany
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[3] Sandoz Biopharmaceut, Clin Pharmacol, Holzkirchen, Germany
[4] Univ Manchester, Ctr Appl Pharmacokinet Res CAPKR, Manchester, Lancs, England
[5] DDI Workshop Org, Fac Int Marbach, Gelnhausen, Germany
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 58卷 / 06期
关键词
SEROTONIN REUPTAKE; OATP TRANSPORTERS; ELDERLY-PATIENTS; P-GLYCOPROTEIN; HUMAN LIVER; METABOLISM; PHARMACOKINETICS; CONSEQUENCES; INHIBITION; MEDICATION;
D O I
10.1002/jcph.1088
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:704 / 716
页数:13
相关论文
共 50 条
  • [22] Drug-Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?
    Bourdin, Venceslas
    Bigot, William
    Vanjak, Anthony
    Burlacu, Ruxandra
    Lopes, Amanda
    Champion, Karine
    Depond, Audrey
    Amador-Borrero, Blanca
    Sene, Damien
    Comarmond, Chloe
    Mouly, Stephane
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [23] Drug-drug interactions in HCV therapy: Still relevant for clinical practice?
    Schulte, Benjamin
    Wubbolding, Maximilian
    Port, Kerstin
    Manns, Michael P.
    Back, David
    Marra, Fiona
    Cornberg, Markus
    Maasoumy, Benjamin
    zu Siederdissen, Christoph Hoener
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E240 - E240
  • [24] BENZODIAZEPINE DRUG-DRUG INTERACTIONS COMMONLY OCCURRING IN CLINICAL-PRACTICE
    ABERNETHY, DR
    GREENBLATT, DJ
    OCHS, HR
    SHADER, RI
    CURRENT MEDICAL RESEARCH AND OPINION, 1984, 8 : 80 - 93
  • [25] Editorial: Drug-drug interactions in pharmacology
    Pichini, Simona
    Di Trana, Annagiulia
    Garcia-Algar, Oscar
    Busardo, Francesco Paolo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [26] Phytocannabinoid drug-drug interactions and their clinical implications
    Silva, Daniela Amaral
    Pate, David W.
    Clark, Robert D.
    Davies, Neal M.
    El-Kadi, Ayman O. S.
    Lobenberg, Raimar
    PHARMACOLOGY & THERAPEUTICS, 2020, 215
  • [27] CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS WITH DAROLUTAMIDE
    Floyd, Rebecca
    Sutton, Jennifer
    Olivier, Kara
    Zurth, Christian
    Smith, Matthew R.
    Shore, Neal
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [28] Drug-drug interaction programs in clinical practice
    Pham, P. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) : 396 - 398
  • [29] THE CLINICAL RELEVANCE OF DRUG-DRUG AND DRUG-HERBAL INTERACTIONS
    Schwab, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 1 - 1
  • [30] PREDICTION OF FOOD-DRUG INTERACTIONS
    ALI, HM
    PHARMACY INTERNATIONAL, 1982, 3 (03): : 102 - 102